What question did this study set out to answer?

This review aims to explore calcium sensitizers as a novel approach for treating heart failure.

January 1, 1995Journal of Cardiovascular Pharmacology

Will Calcium Sensitizers Play a Role in the Treatment of Heart Failure?

View Full Paper

Ask AI

Bookmark

Why the study?

Do calcium sensitizers improve myocardial contractility without the adverse effects of traditional inotropes in patients with congestive heart failure?

Population

Patients with congestive heart failure (CHF)

Comparison

Calcium sensitizers vs Traditional inotropic agents

Design

Review

Authors

JNJens Erik Nielsen‐KudskInterventional Cardiology JAJan AldershvileStatens Serum Institut

Discussion

Member takes

Implication

May reduce proarrhythmic risk versus traditional inotropes in HF; leaves open confirmation in clinical trials.

Key Points

This review aims to explore calcium sensitizers as a novel approach for treating heart failure.
Overview of inotropic agents and their limitations in treatment effectiveness.
Description of calcium sensitization mechanisms and specific compounds like pimobendan and levosimendan.
Discussion on the adverse effects and hemodynamic profiles relative to existing treatments.
Calcium sensitizers enhance myocardial contractility without increasing cytosolic Ca2+ levels.
These agents may reduce the risk of calcium overload and favorably impact oxygen consumption.
Potential adverse effect includes inhibition of cardiac relaxation, a concern for long-term use.

Structured PICO

Do calcium sensitizers improve myocardial contractility without the adverse effects of traditional inotropes in patients with congestive heart failure?

Population

Patients with congestive heart failure (CHF)

Intervention

Calcium sensitizers (e.g., pimobendan, levosimendan, MCI-154, EMD 53998, HMD 57033)

Comparator

Traditional inotropic agents (cAMP-dependent or cAMP-independent)

Calcium sensitizers represent a promising novel pharmacological approach for heart failure that enhances contractility without increasing cytosolic calcium, potentially avoiding the proarrhythmic risks of traditional inotropes.

Limitations

Clinical data on Ca2+ sensitizers are very sparse

Cite This Study

Nielsen‐Kudsk et al. (1995) studied this question.

synapsesocial.com/papers/6a70c8a5fe4101aa97e04f1f https://doi.org/10.1097/00005344-199506261-00011

View Full Paper

Ask AI

Bookmark

Will Calcium Sensitizers Play a Role in the Treatment of Heart Failure?

Discussion

Member takes

Implication

Key Points

Structured PICO

Limitations

Cite This Study

Will Calcium Sensitizers Play a Role in the Treatment of Heart Failure?

Discussion

Member takes

Implication

Key Points

Structured PICO

Limitations

Cite This Study

Also Consider

Also Consider